Breaking News

Underutilized child care in the United States Secretary Antony J. Blinken and Chilean Foreign Minister Antonia Urrejola at a joint press conference – United States Department of State United States Attorney’s Office for the District of Maryland Prosecutes Three Men on Violent Felony Charges of Domestic Abuse Secretary Antony J. Blinken in conversation with YLAI alumni – United States Department of State On the departure of Baquer Namazi from Iran – US Department of State South Dakota is part of the U.S. Department of Justice’s broad efforts to protect the elderly Alleged major Bolivian drug trafficker extradited from Argentina to United States Opinion: The United States’ War Against Russian Disinformation: Is the GEC a Worthy Target? | Global Risk Insights Gun Violence in the United States | NEJM US-Saudi relations take a hit as OPEC cuts oil production

Joe BALINTFY, Chief (Acting), Media Relations Branch, Communications Office and amp; Public link (OCPL).

Joe BALINTFY, Chief (Acting), Media Relations Branch, Communications Office and amp; Public link (OCPL).

It is a prestigious success to publish your research work in a peer-reviewed scientific journal. Congratulations, you are reaching an important audience! But what else can be done to share your findings and connect more broadly? The answer is: collaborate with science communicators!

The NIA Public Communications and Liaison Office (OCPL) team strives to convey clear and accurate scientific and related information to diverse audiences. In fact, the dissemination of content on aging and advances in research to the public, health professionals and the scientific community, among others, is a key part of the mission and strategic direction plan of the NIA. In addition, your achievements are our achievements and we want to help you spread the word.

An early heads-up is essential

For all NIA-supported researchers, whether on-site at NIH laboratories or at a fellowship institution, a key guideline is to connect with your organization’s communications staff when your article has been accepted. for publication. Here at NIA OCPL, we’d prefer to know recently accepted articles three or four weeks in advance, and we’ll appreciate it even more when we include a brief, simple summary of what makes your science new, different, and meaningful.

Speaking of simple language, it takes both skill and time to translate complex technical information from research papers into communications that are accurate and resonate with non-scientific audiences, including, among others, the general public and Congress. With sufficient time, communications staff can also provide more strategic outreach guidance, some of which can take weeks, due to broader review and verification requirements.

Different options for reaching audiences

Search news is not universal, so we usually create a personalized outreach plan. In general, however, for a very significant finding, something that fundamentally changes the scientific landscape or has important clinical implications, long enough, we could recommend a press release to capture the interest of the mainstream media. In cases where science may not be attractive news to a wider audience, mostly public, but it is still an important step forward in the field, we have other options, such as a featured research article or a report on the NIA website and / or Amplification of social networks (for all of the above) via Twitter and Facebook.

Acknowledgments

Regardless of the ways in which we share science, we need to convey the connection with NIH funding. Please remember:

Contact your communications collaborators

Not sure if your article is newsworthy or unclear about how to make your findings relevant to the professional audience? Scientific communicators can help, either here at the NIH or at your own grant organization. We love a good research history, always maintain the confidentiality of manuscripts, and respect the journal’s embargo policies. Contact NIA Communicators at NIAPressTeam@mail.nih.gov or 301-496-1752.

When must IRB review occur?

An IRB must conduct a continuous review of the research at intervals appropriate to the degree of risk, but not less than once a year (45 CFR 46109 (e)).

What is the IRB rule? Under FDA regulations, an IRB is a duly constituted group that has been formally designated to review and monitor biomedical research with human subjects. According to FDA regulations, an IRB has the authority to approve, require modifications (to ensure approval), or disapprove the investigation.

What is IRB Continuing review and when should it occur?

What is continuous review? If you wish to continue working on a study beyond its expiration date, you must submit the study to the IRB for approval of the ongoing review. The IRB reviews the study again to determine if it is appropriate for the study to continue as it is or with modifications.

What requires an IRB review?

FDA regulations generally require IRB review and approval of research that includes FDA-regulated products (e.g., research drugs, biologics, medical devices, and dietary supplements) (21 CFR Part 56).

What is situational cognitive vulnerability?

2. Situational cognitive vulnerability: Subjects do not have capacity, but are in situations that do not allow them to exercise their abilities effectively. This can happen when a subject is distracted or during an emergency situation, such as an acute illness or injury.

What is meant by cognitive vulnerabilities? a set of beliefs or attitudes designed to make a person vulnerable to emotional disorders such as depression and anxiety. Examples include perfectionism, dependence, and sociotropy.

What are some examples of vulnerable populations in cognitive psychology?

There are some groups that have been identified by federal regulations as “vulnerable populations”: pregnant women and fetuses, minors, prisoners, people with reduced mental capacity, and educationally or economically disadvantaged.

What are the 4 main types of vulnerability in healthcare?

Vulnerability in the dictionary: physical, emotional, cognitive.

What is the cognitive vulnerability model?

The Cognitive Vulnerability Model integrates much of the extensive set of research on specific fears and phobias into a unifying theory of the etiology of fear. The model offers parsimonious explanations for the various characteristics of specific fears and phobias.

Why are the elderly excluded from clinical trials?

Among the identified COVID-19 trials, more than 30% included an upper age limit for patient inclusion. The exclusion of elderly patients from clinical trials is sometimes justified by polypharmacy concerns, comorbidities, consent limitations, and more, in order to preserve patient safety.

Is there an age limit for clinical trials? Clinical trials performed in the adult population typically include patients between the ages of 18 and 64 years. However, drugs should be studied in all age groups, and trial participants should be representative of the patient population receiving therapy in daily medical practice.

Why don t patients participate in clinical trials?

Many people are reluctant to participate because they are afraid. Unknown results and possible side effects are common fears. Researchers may not be able to guarantee results, but patient safety is always the top priority. Patients have rights that protect them, and all trials have imposed supervision.

Who is excluded from clinical trials?

What are the exclusion criteria? Exclusion criteria are a list of characteristics that prevent a person from participating in a clinical trial. These characteristics can range from demographic information such as age, gender, or race to something as complex as comorbidities, organ dysfunction, or the use of other medications.

Which of the following is a developmental task of the elderly?

Havinghurst lists the typical developmental tasks that people over the age of 60 face: adapting to a decrease in physical strength, adapting to retirement and reduced income, accepting the death of a spouse , maintaining social relationships with people his age, accepting and adapting to social changes …

What is a development task? A developmental task is a task that arises in or around a certain period of life, the unsuccessful achievement of which leads to the inability to perform the tasks associated with the next period or stage of life. Development task. 1.

What are the 5 developmental stages of life?

The five stages of child development include the newborn, infant, infant, preschool, and school age stages. Children experience various changes in their physical, speech, intellectual, and cognitive development gradually into adolescence.

What are the stages of developmental task?

Havighurst’s model of developmental tasks includes six stages of life: childhood and early childhood from birth to age 5, average childhood between 6 and 12 years, adolescence between 13 and 18 years. , early adulthood between 19 and 30 years, middle age between 30 and 30 years. 60, and later maturity, which is from 60 years.

What are examples of developmental tasks?

In young adulthood, developmental tasks are located primarily in family, work, and social life. Family-related developmental tasks are described as finding a partner, learning to live with a partner, having and raising children, and managing the family home.

Leave a Reply

Your email address will not be published.